Lybrido(s)@home: a double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction.

Trial Profile

Lybrido(s)@home: a double blind, randomized, cross-over placebo controlled study to investigate the subjective and physiological efficacy and safety of Lybrido and Lybridos in the domestic setting in healthy female subjects with Female Sexual Dysfunction.

Completed
Phase of Trial: Phase II

Latest Information Update: 26 Nov 2013

At a glance

  • Drugs Buspirone/testosterone (Primary) ; Sildenafil/testosterone (Primary)
  • Indications Female sexual dysfunction
  • Focus Therapeutic Use
  • Acronyms @HOME; AT-HOME
  • Sponsors Emotional Brain
  • Most Recent Events

    • 15 Mar 2012 Actual end date changed from 12 Feb 2009 to 15 Oct 2009 as reported by European Clinical Trials Database.
    • 22 Oct 2009 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top